ESMO 2018 | Preventative and prognostic screening for BRCA mutations

Name: Preventative and prognostic screening for BRCA mutations
Uploaded: 2018-11-29T14:22:45.000Z
Duration: 1 min
Description: Domenica Lorusso, MD, PhD, of the IRCCS National Cancer Institute, Milan, Italy, discusses the poor diagnostics for ovarian cancer, at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany. Preventative BRCA testing, for patients and extended family, is currently the best prognostic tool.

Domenica Lorusso • 29 Nov 2018

ESMO 2018

Gynecological Cancer Ovarian Cancer Olaparib

SOLO-1

Domenica Lorusso, MD, PhD, of the IRCCS National Cancer Institute, Milan, Italy, discusses the poor diagnostics for ovarian cancer, at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany. Preventative BRCA testing, for patients and extended family, is currently the best prognostic tool.